Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum - Wikidata - awgldk - TriplyDB

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

http://www.wikidata.org/entity/Q28469180

about

Prospects for malaria eradication in sub-Saharan Africa Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan The potential contribution of mass treatment to the control of Plasmodium falciparum malaria Plasmodium falciparum antigens on the surface of the gametocyte-infected erythrocyte Heritability of the human infectious reservoir of malaria parasites Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?Comparison of microscopy, nested-PCR, and Real-Time-PCR assays using high-throughput screening of pooled samples for diagnosis of malaria in asymptomatic carriers from areas of endemicity in Myanmar.The role of submicroscopic parasitemia in malaria transmission: what is the evidence?Carriage of sub-microscopic sexual and asexual Plasmodium falciparum stages in the dry season at Navrongo, Ghana.Burden of asymptomatic malaria among a tribal population in a forested village of central India: a hidden challenge for malaria control in India.Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus Malaria gametocytogenesis.Treatment of Asymptomatic Carriers of Plasmodium falciparum with Artemether-Lumefantrine: Impact on the Prevalence of Anemia.Monitoring, characterization and control of chronic, symptomatic malaria infections in rural Zambia through monthly household visits by paid community health workers Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination Dynamics of malaria transmission and susceptibility to clinical malaria episodes following treatment of Plasmodium falciparum asymptomatic carriers: results of a cluster-randomized study of community-wide screening and treatment, and a parallel ento Evaluation of Plasmodium falciparum gametocyte detection in different patient material.Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.Human-to-mosquito transmission efficiency increases as malaria is controlled.The relationship between Plasmodium infection, anaemia and nutritional status in asymptomatic children aged under five years living in stable transmission zones in Kinshasa, Democratic Republic of Congo.The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysis.Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia.Gametocyte Clearance Kinetics Determined by Quantitative Magnetic Fractionation in Melanesian Children with Uncomplicated Malaria Treated with Artemisinin Combination Therapy.Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population.A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso.Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials High prevalence of asymptomatic malaria in a tribal population in eastern India.A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya.Gametocytes: insights gained during a decade of molecular monitoring.Comparison of the diagnostic performance of microscopic examination with nested polymerase chain reaction for optimum malaria diagnosis in Upper Myanmar Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.Novel approaches in antimalarial drug discovery.Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.Biology of Malaria Transmission.Coartem(®): a decade of patient-centric malaria management.

P2860

Q21144336-BF6B8DB0-118C-4813-984D-11FAE9C7613D Q24188070-62C9C374-E1CE-4AC1-BE2A-F42FF4E06B94 Q24193716-B53A4AEC-8068-498B-9DAE-4B635BC83ED1 Q28469316-40786F0E-222D-45AD-96AA-BAD6427BD3C6 Q28471717-37259A40-D0ED-4447-8EE9-7D99EFA895D0 Q28478260-736F591C-3A9F-462B-99FC-DE94229403B4 Q33338492-5206BC1A-B9DB-4AEB-A035-29588AB9CFF6 Q33627561-DE2CF3CC-654D-4305-B6E2-901E629D062E Q33670134-35CD3E5C-2720-4956-8939-8B00CB2E0ADA Q33703573-ED990A06-2676-4465-BB3D-F378F3E19CF9 Q33724777-96DA30FF-8C22-4A43-AF3C-8B7D4DFA6AB8 Q33725434-F10BAA47-05F6-4C34-9EE5-73722B1527CB Q33759006-56641347-3E26-4038-A102-5B1C7CFB5A71 Q33817605-9BE98B23-85AA-4DC6-ADC6-38CDADDBEA2F Q33894262-6DCDEEF1-6D89-473F-80C5-12940C5C5322 Q33939028-70DBED35-A304-4D9E-987A-44CF029E96F6 Q33960088-E9716397-5964-45CD-AC3F-6FDC05EA6454 Q34177472-D403540C-FF1B-4A9C-83C9-9E875B5D1EF4 Q34478989-7201203D-FB6B-44C6-AD5B-849CC8D481C7 Q34523425-409DA05E-00C7-40F3-94AC-D9A0152F4754 Q34677891-99871694-35CD-4603-B8C2-FCA270507F1A Q35022983-7C3BD83E-418B-4E76-B3DE-D94584DDEA64 Q35108578-BE8804B6-E9A9-4AB6-A359-5F415BAEBC18 Q35147721-0D83EE0C-5542-4333-909F-44EA5234A715 Q35179184-756F1E3F-FBAB-4798-8F32-797212A5B2F0 Q35737774-AD884986-CF9D-4778-BCC0-F2EDBED32E26 Q35860086-D152515C-7FA9-4437-86E6-192CA6F6433E Q36617963-B16107F6-B569-4DFF-9F18-1A770A23D551 Q36667585-311D012A-FE3A-497F-BF89-799FA3EF856B Q36690099-38D9FAFB-455A-4255-8245-C1259D68F6F3 Q36800842-D5A17325-088D-4612-AD7D-F2053BA14E5A Q36826719-6627C298-DD64-4E07-B2F4-B496B049E02D Q37010425-E0589401-6335-4FE3-A610-13DD4A03A164 Q37272969-2F031328-4AF2-4943-8E96-EE283E66AC58 Q37708309-8A3F4B1A-004F-4EB9-9FD5-F44E4D6EEEE8 Q37857327-A80FC7F2-16CE-452A-9D50-757460086A7E Q38148787-1A2CC6D5-413E-4DAA-8509-E3A624C00B15 Q38818196-1436246A-45AD-41E7-A52A-A83BC1FAF0B0 Q39005901-27EC9624-D9CA-4FFE-9699-7337A5A8B433 Q39042892-1F3AD4D4-6034-4043-8115-2AD60BF9B206

P2860

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

http://www.wikidata.org/entity/Q28469180

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@ast

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@en

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@nl

type

label

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@ast

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@en

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@nl

prefLabel

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@ast

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@en

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@nl

P1433

Q28469180-042C75A3-7ABB-44F4-91B0-0DCB95B3F541

P1476

Q28469180-60CED894-21DF-4C58-9459-90EBF2BAB0BC

P2093

Q28469180-41E49F0B-2B7A-407D-89A1-4022AEEC18BF

Q28469180-6E1D471A-AE5A-44A3-A5C5-A46B5BA39022

Q28469180-74D272A8-E871-4B6B-AA87-EC5D5D03788B

Q28469180-EF76872D-1421-4670-88AB-7B2196DCF96D

P2860

Q28469180-02BA82A6-92C2-4A82-BAD1-4D2E2EF4A301

Q28469180-03BA5D42-1306-4629-8194-E5436EB04C19

Q28469180-10CCFAE1-8350-4298-86B9-66C9827DF67C

Q28469180-1470C854-E130-41F0-942F-427E9AB4961A

Q28469180-15B2F3A1-C84E-46F6-8FF2-45A8F417B486

Q28469180-180392FB-1973-4D49-A59A-A2A3B6AF7CA5

Q28469180-2C1ED3F7-D406-41B3-B73D-BF9FA90ECD26

Q28469180-32990F52-CA83-4FB5-B2A9-4CA6D1DBC8AA

Q28469180-38035873-4B4A-43AF-92F8-D7F974263880

Q28469180-4FA1AB1C-94BB-4B7B-9323-0091EF6BF902

P304

Q28469180-8D1CF178-24C2-418E-99D6-37870E4B952C

P31

Q28469180-6730655E-AD1B-490B-BAA4-365B95D90064

P356

Q28469180-C45B4E3F-C7D4-4D38-A7AC-0AB5EA6A94A7

P407

Q28469180-5E688492-386F-43AD-8841-7CACB03DD610

P433

Q28469180-9D798626-C4AB-4526-82FC-A7B2CB536303

P478

Q28469180-F17B8670-ADF4-46BA-985A-0EB24BD87CED

P50

Q28469180-12E95CC3-AD28-4F23-A4BD-068FB1805D29

Q28469180-B8E474DE-507A-4C6F-9431-EFF1DDCD78DD

P577

Q28469180-EFED8BAB-0CCC-41F6-90A3-83AE4E6A4CB7

P5875

Q28469180-602781D5-8270-4B1B-A51C-C101E28A58C1

P698

Q28469180-7E3CEE63-5B87-43A2-A131-19473CD1DCC4

P921

Q28469180-A37C542E-EEE5-47C7-82C5-9D61B1849BF9

P932

Q28469180-24815FEC-14CE-4975-9CA2-2B7CB2F31288

P356

JOURNAL.PCTR.0010020

P1433

PLOS Clinical Trials

P1476

Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum

@en

P2093

Colin Sutherland

http://www.w3.org/2001/XMLSchema#string

Geoffrey Targett

http://www.w3.org/2001/XMLSchema#string

Samuel Dunyo

http://www.w3.org/2001/XMLSchema#string

Tansy Edwards

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether

Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya

Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.

Comparison of two simple methods for determining malaria parasite density.

Mass administrations of antimalarial drugs.

The effect of mass administration of sulfadoxine-pyrimethamine combined with artesunate on malaria incidence: a double-blind, community-randomized, placebo-controlled trial in The Gambia.

Comparison of artesunate and chloroquine activities against Plasmodium vivax gametocytes.

Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes.

Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial.

Comparison of two strategies for control of malaria within a primary health care programme in the Gambia.

P304

e20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PCTR.0010020

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Paul J. Milligan

Margaret Pinder

P577

2006-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6782345

http://www.w3.org/2001/XMLSchema#string

P698

17013431

http://www.w3.org/2001/XMLSchema#string

P921

Plasmodium falciparum

P932

1851719

http://www.w3.org/2001/XMLSchema#string